Remote Monitoring

Remote cardiac monitoring technologies enable patient health to be tracked outside the clinical setting. It can be used for longer term monitoring to help diagnosis arrhythmias or other cardiac conditions. Remote monitoring also can keep tabs on chronic conditions such as heart failure or hypertension and alert clinicians to worsening symptoms to avoid an acute care episode or hospitalization.

RSS icon
cardiologist patient heart compensation starting salary 2022 interventional cardiologist

Researchers awarded $31M to study conduction system pacing among heart failure patients

“Once the study begins, it will likely be one of the largest heart pacing clinical trials happening in the world over the next few years," one specialist said. 

smartphone stethoscope Echoes

Smartphones show potential to double as electronic stethoscopes

The application, called Echoes, was designed with help from the British Heart Foundation and Evelina Children’s Heart Organization. It uses an iPhone's built-in microphone to capture recordings of the user's heart. 

Thumbnail

Researchers awarded $37M to see if Apple Watch can lower stroke risk among AFib patients

Could wearables help AFib patients take fewer blood-thinning medications and reduce their risk of stroke? The team behind a new seven-year analysis hopes to find out. 

The U.S. Food and Drug Administration (FDA) has granted the first pediatric indication for use for an implantable cardiac monitor to Medtronic. The Linq II Insertable Cardiac Monitor (ICM) system is the first such device receive 510(k) clearance for use in pediatric patients over the age of 2 who have heart rhythm abnormalities and require long-term, continuous monitoring.

FDA grants new pediatric indication for Medtronic Linq II implantable cardiac monitor 

The FDA granted the first pediatric indication for an implantable cardiac monitor. The Linq II can be used in pediatric patients over the age of 2 for up to 4.5 years of long-term, continuous monitoring. 

Thumbnail

New expert guidelines highlight the importance of quickly diagnosing and treating CIED infections

Though removal of the affected CIED is typically the smartest treatment option—and one supported by specialty groups all over the world—a majority of patients keep living with the device, often resulting in hospitalization or even death.

FDA announces recall of nearly 88,000 implantable cardiac devices due to risk of serious injury or death

The recall is related to short circuit protection (SCP) alerts that were causing the devices to send reduced-energy electric shocks. There have been 27 customer complaints about the issue so far.

Thumbnail

AFib screening using wearable devices found to be cost-effective for patients as young as 50

While current guidelines endorse screening for people aged 65 and above, a massive simulation published in JAMA Health Forum suggests that cost-effectiveness may extend to even younger age groups.

cardiac scale bodyport fda clearance

Cardiac scale gains FDA clearance, putting patients 1 step away from a heart assessment

The newly cleared device works like a traditional scale, but it captures more data than just the user's weight. 

Displaying 73 - 80 of 106
Design by Adaptive Theme